BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 12422595)

  • 1. Procalcitonin levels in patients with Lyme borreliosis.
    Lotric-Furlan S; Maraspin-Carman V; Cimperman J; Ogrinc K; Stopar T; Strle F
    Wien Klin Wochenschr; 2002 Jul; 114(13-14):530-2. PubMed ID: 12422595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphoproliferative responses to Borrelia burgdorferi in patients with erythema migrans, acrodermatitis chronica atrophicans, lymphadenosis benigna cutis, and morphea.
    Buechner SA; Lautenschlager S; Itin P; Bircher A; Erb P
    Arch Dermatol; 1995 Jun; 131(6):673-7. PubMed ID: 7778918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid findings in patients with symptoms suggesting chronic Lyme borreliosis.
    Ogrinc K; Lotric-Furlan S; Maraspin V; Cimperman J; Ruzić-Sabljić E; Strle F
    Wien Klin Wochenschr; 2002 Jul; 114(13-14):535-8. PubMed ID: 12422597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymerase chain reaction in diagnosis of Borrelia burgdorferi infections and studies on taxonomic classification.
    Lebech AM
    APMIS Suppl; 2002; (105):1-40. PubMed ID: 11985118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of flagellum and sonicate antigens for serological diagnosis of Lyme borreliosis.
    Karlsson M; Stiernstedt G; Granström M; Asbrink E; Wretlind B
    Eur J Clin Microbiol Infect Dis; 1990 Mar; 9(3):169-77. PubMed ID: 2186910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of immunofluorescence assay (IFA) and LIAISON in patients with different clinical manifestations of Lyme borreliosis.
    Cerar T; Ruzic-Sabljic E; Cimperman J; Strle F
    Wien Klin Wochenschr; 2006 Nov; 118(21-22):686-90. PubMed ID: 17160608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A two year prospective study to compare culture and polymerase chain reaction amplification for the detection and diagnosis of Lyme borreliosis.
    Picken MM; Picken RN; Han D; Cheng Y; Ruzic-Sabljic E; Cimperman J; Maraspin V; Lotric-Furlan S; Strle F
    Mol Pathol; 1997 Aug; 50(4):186-93. PubMed ID: 9350301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limitation of serological testing for Lyme borreliosis: evaluation of ELISA and western blot in comparison with PCR and culture methods.
    Tylewska-Wierzbanowska S; Chmielewski T
    Wien Klin Wochenschr; 2002 Jul; 114(13-14):601-5. PubMed ID: 12422608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Borrelia-specific interferon-gamma and interleukin-4 secretion in cerebrospinal fluid and blood during Lyme borreliosis in humans: association with clinical outcome.
    Widhe M; Jarefors S; Ekerfelt C; Vrethem M; Bergstrom S; Forsberg P; Ernerudh J
    J Infect Dis; 2004 May; 189(10):1881-91. PubMed ID: 15122525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Children with multiple erythema migrans: are there any pre-treatment symptoms and/or signs suggestive for central nervous system involvement?
    Arnez M; Pleterski-Rigler D; Luznik-Bufon T; Ruzić-Sabljić E; Strle F
    Wien Klin Wochenschr; 2002 Jul; 114(13-14):524-9. PubMed ID: 12422594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acrodermatitis chronica atrophicans].
    Wittmann D; Heppt M; Ruzicka T
    MMW Fortschr Med; 2016 Mar; 158(6):64, 66-7. PubMed ID: 27084166
    [No Abstract]   [Full Text] [Related]  

  • 12. Skin manifestations of lyme borreliosis: diagnosis and management.
    Müllegger RR; Glatz M
    Am J Clin Dermatol; 2008; 9(6):355-68. PubMed ID: 18973402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous manifestations of Lyme borreliosis.
    Berger BW
    Rheum Dis Clin North Am; 1989 Nov; 15(4):627-34. PubMed ID: 2685922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective study of serologic tests for lyme disease.
    Steere AC; McHugh G; Damle N; Sikand VK
    Clin Infect Dis; 2008 Jul; 47(2):188-95. PubMed ID: 18532885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Reddish-blue color lower leg with distinct vessel design. "Venous insufficiency" was Lyme borreliosis].
    Jäckle R
    MMW Fortschr Med; 2003 Jun; 145(24):18. PubMed ID: 12866293
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparison of test with antigen VlsE (C6) with tests with recombinant antigens in patients with Lyme borreliosis].
    Zajkowska JM; Kondrusik M; Pancewicz SA; Grygorczuk S; Jamiołkowski J; Stalewska J
    Pol Merkur Lekarski; 2007 Aug; 23(134):95-9. PubMed ID: 18044336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lyme disease: European perspective.
    Stanek G; Strle F
    Infect Dis Clin North Am; 2008 Jun; 22(2):327-39, vii. PubMed ID: 18452805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lyme borreliosis in adults].
    Ljøstad U; Mygland A
    Tidsskr Nor Laegeforen; 2008 May; 128(10):1175-8. PubMed ID: 18480867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Skin manifestations in Lyme borreliosis. 6: Acrodermatitis chronica atrophicans (ACA)].
    Hassler D
    Fortschr Med; 1998 Feb; 116(5):34-6. PubMed ID: 9553302
    [No Abstract]   [Full Text] [Related]  

  • 20. [Guideline 'Lyme borreliosis'].
    Speelman P; de Jongh BM; Wolfs TF; Wittenberg J;
    Ned Tijdschr Geneeskd; 2004 Apr; 148(14):659-63. PubMed ID: 15106316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.